View Item 

Show simple item record

MIP‐3α and MIP‐1α rapidly mobilize dendritic cell precursors into the peripheral blood
dc.contributor.authorHe, Shan
dc.contributor.authorCao, Qi
dc.contributor.authorYoneyama, Hiroyuki
dc.contributor.authorGe, Hailiang
dc.contributor.authorZhang, Yi
dc.contributor.authorZhang, Yanyun
dc.date.accessioned2018-02-05T16:27:51Z
dc.date.available2018-02-05T16:27:51Z
dc.date.issued2008-12
dc.identifier.citationHe, Shan; Cao, Qi; Yoneyama, Hiroyuki; Ge, Hailiang; Zhang, Yi; Zhang, Yanyun (2008). "MIP‐3α and MIP‐1α rapidly mobilize dendritic cell precursors into the peripheral blood." Journal of Leukocyte Biology 84(6): 1549-1556.
dc.identifier.issn0741-5400
dc.identifier.issn1938-3673
dc.identifier.urihttps://hdl.handle.net/2027.42/141122
dc.publisherWiley Periodicals, Inc.
dc.subject.otherchemokine
dc.subject.otherDC‐based vaccine
dc.subject.otherrecruited DC
dc.titleMIP‐3α and MIP‐1α rapidly mobilize dendritic cell precursors into the peripheral blood
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMicrobiology and Immunology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.contributor.affiliationumDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA
dc.contributor.affiliationotherDepartment of Molecular Preventive Medicine, School of Medicine, The University of Tokyo, Tokyo, Japan; and
dc.contributor.affiliationotherInstitute of Health Sciences and Shanghai Institute of Immunology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences and Shanghai Jiao Tong University School of Medicine, Institutes of Medical Sciences, Shanghai, China;
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/141122/1/jlb1549.pdf
dc.identifier.doi10.1189/jlb.0708420
dc.identifier.sourceJournal of Leukocyte Biology
dc.identifier.citedreferenceZhu, L., Ji, F., Wang, Y., Zhang, Y., Liu, Q., Zhang, J. Z., Matsushima, K., Cao, Q., Zhang, Y. Y. ( 2006 ) Synovial autoreactive T cells in rheumatoid arthritis resist IDO‐mediated inhibition. J. Immunol. 177, 8226 – 8233.
dc.identifier.citedreferenceOppenheim, J. J., Yang, D., Biragyn, A., Howard, O. M., Plotz, P. ( 2002 ) Chemokine receptors on dendritic cells promote autoimmune reactions. Arthritis Res. 4, (Suppl. 3), S183 – S188.
dc.identifier.citedreferenceSallusto, F., Lanzavecchia, A. ( 2000 ) Understanding dendritic cell and T‐lymphocyte traffic through the analysis of chemokine receptor expression. Immunol. Rev. 177, 134 – 140.
dc.identifier.citedreferenceCyster, J. G. ( 1999 ) Chemokines and cell migration in secondary lymphoid organs. Science 286, 2098 – 2102.
dc.identifier.citedreferenceGlass, W. G., Rosenberg, H. F., Murphy, P. M. ( 2003 ) Chemokine regulation of inflammation during acute viral infection. Curr. Opin. Allergy Clin. Immunol. 3, 467 – 473.
dc.identifier.citedreferenceMelchers, F., Rolink, A. G., Schaniel, C. ( 1999 ) The role of chemokines in regulating cell migration during humoral immune responses. Cell 99, 351 – 354.
dc.identifier.citedreferenceCaux, C., Vanbervliet, B., Massacrier, C., Ait‐Yahia, S., Vaure, C., Chemin, K., And Dieu‐Nosjean, M. C., Vicari, A. ( 2002 ) Regulation of dendritic cell recruitment by chemokines. Transplantation 73, S7 – 11.
dc.identifier.citedreferenceYoneyama, H., Matsuno, K., Zhang, Y., Murai, M., Itakura, M., Ishikawa, S., Hasegawa, G., Naito, M., Asakura, H., Matsushima, K. ( 2001 ) Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tract‐associated lymphoid tissue, in a granulomatous liver disease. J. Exp. Med. 193, 35 – 49.
dc.identifier.citedreferenceZhang, Y., Yoneyama, H., Wang, Y., Ishikawa, S., Hashimoto, S., Gao, J. L., Murphy, P., Matsushima, K. ( 2004 ) Mobilization of dendritic cell precursors into the circulation by administration of MIP‐1α in mice. J. Natl. Cancer Inst. 96, 201 – 209.
dc.identifier.citedreferenceGao, J. L., Wynn, T. A., Chang, Y., Lee, E. J., Broxmeyer, H. E., Cooper, S., Tiffany, H. L., Westphal, H., Kwon‐Chung, J., Murphy, P. M. ( 1997 ) Impaired host defense, hematopoiesis, granulomatous inflammation and type 1‐type 2 cytokine balance in mice lacking CC chemokine receptor 1. J. Exp. Med. 185, 1959 – 1968.
dc.identifier.citedreferenceMurai, M., Yoneyama, H., Ezaki, T., Suematsu, M., Terashima, Y., Harada, A., Hamada, H., Asakura, H., Ishikawa, H., Matsushima, K. ( 2003 ) Peyers’s patch is the essential site in initiating murine acute and lethal graft‐versus‐host reaction. Nat. Immunol. 4, 154 – 160.
dc.identifier.citedreferenceBueler, H., Mulligan, R. C. ( 1996 ) Induction of antigen specific tumor immunity by genetic and cellular vaccines against MAGE: enhanced tumor protection by coexpression of granulocyte‐macrophage colony‐stimulating factor and B7–1. Mol. Med. 2, 545 – 555.
dc.identifier.citedreferenceZhang, Y., Mukaida, N., Wang, J., Harada, A., Akiyama, M., Matsushima, K. ( 1997 ) Induction of dendritic cell differentiation by granulocyte‐macrophage colony‐stimulating factor, stem cell factor, and tumor necrosis factor α in vitro from lineage phenotypes‐negative c‐kit + murine hematopoietic progenitor cells. Blood 90, 4842 – 4853.
dc.identifier.citedreferenceZhang, Y., Harada, A., Wang, J. B., Zhang, Y. Y., Hashimoto, S., Naito, M., Matshshima, K. ( 1998 ) Bifurcated dendritic cell differentiation in vitro from murine lineage phenotype‐negative c‐kit + bone marrow hematopoietic progenitor cells. Blood 92, 118 – 128.
dc.identifier.citedreferenceReed, D. S., Romero, P., Rimoldi, D., Cerottini, J. C., Schaack, J., Jongeneel, C. V. ( 1997 ) Construction and characterization of a recombinant adenovirus directing expression of the MAGE‐1 tumor‐specific antigen. Int. J. Cancer 72, 1045 – 1055.
dc.identifier.citedreferenceYang, D., Chen, Q., Hoover, D. M., Staley, P., Tucker, K. D., Lubkowski, J., Oppenheim, J. J. ( 2003 ) Many chemokines including CCL20/MIP‐3α display antimicrobial activity. J. Leukoc. Biol. 74, 448 – 455.
dc.identifier.citedreferencePower, C. A., Church, D. J., Meyer, A., Alouani, S., Proudfoot, A. E. I., Clark‐Lewis, I., Sozzani, S., Mantovani, A., Wells, T. N. C. ( 1997 ) Cloning and characterization of a specific receptor for the novel CC chemokine MIP‐3α from lung dendritic cells. J. Exp. Med. 186, 825 – 835.
dc.identifier.citedreferenceByrnes, H. D., Kaminski, H., Mirza, A., Deno, G., Lundell, D., Fine, J. S. ( 1999 ) Macrophage inflammatory protein‐3 β enhances IL‐10 production by activated human peripheral blood monocytes and T cells. J. Immunol. 163, 4715 – 4720.
dc.identifier.citedreferenceKleeff, J., Kusama, T., Rossi, D. L., Ishiwata, T., Maruyama, H., Friess, H., Büchler, M. W., Zlotnik, A., Korc, M. ( 1999 ) Detection and localization of Mip‐3α/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer. Int. J. Cancer 81, 650 – 657.
dc.identifier.citedreferenceWada T., Matsushima K., Kaneko S. ( 2008 ) The role of chemokines in glomerulonephritis. Front. Biosci. 13, 3966 – 3974.
dc.identifier.citedreferenceLukacs‐Kornek, V., Engel, D., Tacke, F., Kurts, C. ( 2008 ) The role of chemokines and their receptors in dendritic cell biology. Front. Biosci. 13, 2238 – 2252.
dc.identifier.citedreferenceDieu, M. C., Vanbervliet, B., Vicari, A., Bridon, J. M., Oldham, E., Aït‐Yahia, S., Brière, F., Zlotnik, A., Lebecque, S., Caux, C. ( 1998 ) Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188, 373 – 382.
dc.identifier.citedreferenceSteinman, R. M., Pope, M. ( 2002 ) Exploiting dendritic cells to improve vaccine efficacy. J. Clin. Invest. 109, 1519 – 1526.
dc.identifier.citedreferenceMocellin, S. ( 2006 ) New strategies to improve the efficacy of colorectal cancer vaccines: from bench to bedside. Curr. Opin. Investig. Drugs 7, 1052 – 1061.
dc.identifier.citedreferenceBanchereau, J., Steinman, R. M. ( 1998 ) Dendritic cells and the control of immumity. Nature 392, 245 – 252.
dc.identifier.citedreferenceWen, H., Schaller, M. A., Dou, Y., Hogaboam, C. M., Kunkel, S. L. ( 2008 ) Dendritic cells at the interface of innate and acquired immunity: the role for epigenetic changes. J. Leukoc. Biol. 83, 439 – 446.
dc.identifier.citedreferenceTamada, K., Shimozaki, K., Chapoval, A. I., Zhai, Y., Su, J., Chen, S. F., Hsieh, S. L., Nagata, S., Ni, J., Chen, L. ( 2000 ) LIGHT, a TNF‐like molecule, costimulates T cell proliferation and is required for dendritic cell‐mediated allogeneic T cell response. J. Immunol. 164, 4105 – 4110.
dc.identifier.citedreferenceNouri‐Shirazi, M., Banchereau, J., Fay, J., Palucka, K. ( 2000 ) Dendritic cell based tumor vaccines. Immunol. Lett. 74, 5 – 10.
dc.identifier.citedreferenceNestle, F. O., Farkas, A., Conrad, C. ( 2005 ) Dendritic‐cell‐based therapeutic vaccination against cancer. Curr. Opin. Immunol. 17, 163 – 169.
dc.identifier.citedreferenceOh, S. T., Kim, C. H., Park, M. Y., Won, E. H., Sohn, H. J., Cho, H. I., Kang, W. K., Hong, Y. K., Kim, T. G. ( 2006 ) Dendritic cells transduced with recombinant adenoviruses induce more efficient anti‐tumor immunity than dendritic cells pulsed with peptide. Vaccine 24, 2860 – 2868.
dc.identifier.citedreferenceMarland, G., Bakker, A. B., Adema, G. J., Figdor, C. G. ( 1996 ) Dendritic cells in immune response induction. Stem Cells 14, 501 – 507.
dc.identifier.citedreferenceFiore, F., Castella, B., Nuschak, B., Bertieri, R., Mariani, S., Bruno, B., Pantaleoni, F., Foglietta, M., Boccadoro, M., Massaia, M. ( 2007 ) Enhanced ability of dendritic cells to stimulate innate and adaptive immunity on short‐term incubation with zoledronic acid. Blood 110, 921 – 927.
dc.identifier.citedreferenceSheng, K. C., Pietersz, G. A., Wright, M. D., Apostolopoulos, V. ( 2005 ) Dendritic cells: activation and maturation‐applications for cancer immunotherapy. Curr. Med. Chem. 12, 1783 – 1800.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
jlb1549.pdf
Size:
384.6KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.